Clinical Trials Logo
  1. Home
  2. Vitreous Hemorrhage
  3. NCT05529589

Comparison of Restoration in Vitreous Hemorrhage Patients With DME After or Not Removing Inner Limiting Membrane

Vitreous Hemorrhage Clinical Trial

Official title:
Comparative Study of Anti-VEGF Effect and Visual Function in Vitreous Hemorrhage Patients With Diabetic Macular Edema After Pars Plana Vitrectomy With Inner Limiting Membrane Peeling or Not

Clinical Trial Summary

This study is conducted to compare the anti-VEGF effect and visual function in vitreous hemorrhage patients with diabetic macular edema after pars plana vitrectomy with inner limiting membrane peeling or not

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05529589
Study type Observational
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Jian Ma, Doctor
Phone 18858299889
Email jian_ma@zju.edu.cn
Status Recruiting
Phase
Start date February 10, 2023
Completion date October 30, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT00411970 - 20- Versus 23- Gauge System for Pars Plana Vitrectomy Phase 4
Completed NCT00155454 - Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy N/A
Completed NCT00000154 - Diabetic Retinopathy Vitrectomy Study (DRVS) Phase 3
Recruiting NCT05514925 - Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy Phase 4
Completed NCT02858076 - Anti-VEGF vs. Prompt Vitrectomy for VH From PDR Phase 2/Phase 3
Completed NCT00596297 - Preoperative Bevacizumab for Vitreous Hemorrhage Phase 1/Phase 2
Completed NCT00198510 - Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage Phase 3
Completed NCT01854593 - Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy Phase 4
Completed NCT04859556 - Performance, Safety and Efficiency Comparison Between 10,000 and 5,000 Cuts Per Minute Vitrectomy Using a 25G Cutter - A Prospective Randomized Controlled Study N/A
Recruiting NCT01824043 - Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage Phase 4
Completed NCT01805297 - Aflibercept Injection for Proliferative Diabetic Retinopathy Phase 2
Completed NCT06383754 - Clareon Intraocular Lens Stability in Vitrectomy Patients: CLOVE Study N/A
Not yet recruiting NCT04346095 - Oral Sedation in Vitreoretinal Surgery Phase 4
Completed NCT00996437 - Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Phase 2/Phase 3
Completed NCT00745498 - Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy N/A
Completed NCT00198497 - Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage Phase 3
Completed NCT00000162 - Branch Vein Occlusion Study Phase 3
Completed NCT05710458 - Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter N/A
Recruiting NCT05588037 - Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery N/A
Completed NCT04712786 - Refractive Changes Following Vitrectomy